Lactate metabolism in cancer: resolving flux, acidity, and lactylation for clinical translation
Lactate is simultaneously a circulating oxidative fuel, a product of cytosolic redox balancing, a proton-coupled transport substrate, a receptor ligand and a precursor for lysine lactylation. In cancer, these functions are often inferred from concentration alone, generating apparently conflicting conclusions about tumor growth, immune function and treatment response. LAPSE is an acronym for Lactate species, Acidity, Producer–recipient pairing, Spatial compartment and Exposure history; we use this framework to separate directional carbon and redox flux from acid stress, receptor signaling and chemically distinct protein modifications. This approach provides a testable mechanistic explanation for suppression of activated effector lymphocytes in chronically acidic tumors and lactate-supported regulatory or myeloid states and the preservation of T-cell stemness by controlled neutral-lactate exposure. We critically appraise selected lactylation mechanisms in terms of stereochemical assignment, precursor tracing, enzyme dependence, site perturbation and functional rescue. Human isotope-tracing studies, early-phase monocarboxylate-transporter inhibition and hyperpolarized carbon-13 imaging demonstrate that lactate metabolism is measurable in patients, but no circulating lactate, tissue-acidity or site-specific lactylation assay is yet a validated predictive biomarker. Clinical translation should therefore prioritize compartment- and lineage-selective interventions, paired tumor and systemic pharmacodynamics, and treatment schedules that preserve normal inter-organ lactate exchange.
Authors
- Ya Xiao
- 李秉枢
- Lian Yang (ORCID: https://orcid.org/0000-0003-4664-2474)
- Jianming Tang
- Yong He
- Shouqi Huang
- Li Hong
- Cheng Liu
- Shasha Hong
Institutions
- Renmin Hospital of Wuhan University (CN)
- Xiangnan University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-11-20
- DOI
- https://doi.org/10.3389/fimmu.2026.1977586
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- China Postdoctoral Science Foundation